A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

2018 health plans outlook: More policy uncertainty likely ahead, but larger market shifts and business trends continue to redefine the sector

by Greg Scott, Vice Chairman, US Health Plans Leader, Deloitte LLP

Looking back on health plan sector developments in 2017, much media attention focused on efforts to repeal and replace the Affordable Care Act (ACA). While the continuing ACA political drama is certainly newsworthy, it’s important to stay focused on larger, abiding trends that are reshaping the health plan sector – and the US health care industry overall.

Read more

2018 outlook: Life sciences firms could see some legislative headwinds, regulatory momentum

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

For many US life sciences and health care companies, 2017 was a year of market and legislative uncertainty. Much of the year was dominated by on-again-off-again efforts to repeal and replace the Affordable Care Act (ACA), which has now turned to discussions about reforming the tax code. For some life sciences companies, this uncertainty created a wait-and-see approach to investments – particularly mergers and acquisitions (M&A).

Read more

2018 outlook: Many hospitals and health systems will be straddling two canoes

by Steve Burrill, Vice Chairman, US Health Care Leader, Deloitte LLP

As we paddle into 2018, many hospitals and health systems are rowing upstream – with a bit of choppy water ahead – straddling two canoes. The smaller canoe is value-based care, and many CEOs are trying to find stable footing. The other shoe remains firmly planted in the larger fee-for-service (FFS) or volume canoe.

In a recent survey conducted by the Deloitte Center for Health Solutions,

Read more